http://panel.opinionhealth.com/ 2011-12-23T08:18:27Z Opinion Health http://panel.opinionhealth.com/r/9870 2011-12-23T08:18:27Z PMLive

Merck and Co has terminated an agreement with Acumen to develop treatments for Alzheimer’s disease the same day it announced it has bought the licence to an R&D programme from Exelixis.

http://panel.opinionhealth.com/r/9869 2011-12-23T08:18:12Z PMLive

Bayer has delivered an optimistic appraisal of its pipeline prospects, highlighting four products which it believes will cross the €1bn sales barrier and become blockbusters.

http://panel.opinionhealth.com/r/9867 2011-12-23T08:17:35Z PMLive

AstraZeneca has signed two licensing deals with Asian drug developers to add new medicines for diabetes and cancer into its development pipeline.

http://panel.opinionhealth.com/r/9866 2011-12-23T08:17:11Z PMLive

Daiichi-Sankyo has halved its net income forecast after agreeing a $500m legal settlement for manufacturing violations by its Ranbaxy Laboratories unit.

http://panel.opinionhealth.com/r/9865 2011-12-23T08:16:53Z PMLive

Novocure has added three senior oncology executives to its global management team to support its new tumour treating fields (TTF) cancer therapy.

http://panel.opinionhealth.com/r/9864 2011-12-23T08:16:36Z

On April 1, the prices of 75 medicines supplied through Australia's Pharmaceutical Benefits Scheme (PBS) will be reduced by an average of 28.7%, saving the government an estimated A$1.9 billion over four years.

http://panel.opinionhealth.com/r/9863 2011-12-23T08:16:20Z

The European Union (EU)'s proposed new directive on public procurement will allow "more scope for negotiating with suppliers," according to the NHS Confederation.

http://panel.opinionhealth.com/r/9862 2011-12-23T08:16:03Z

More than one third of clinical trials conducted by pharmaceutical companies are now being outsourced, a new report has found.

http://panel.opinionhealth.com/r/9861 2011-12-23T08:15:50Z

The US Food and Drug Administration has now joined a probe to investigate the safety of Novartis’ oral multiple sclerosis drug Gilenya (fingolimod) after a patient died within 24 hours of taking the first dose.

http://panel.opinionhealth.com/r/9860 2011-12-23T08:15:34Z

Ranbaxy's stock slipped this week after the firm revealed it would be putting $500 million aside to cover any criminal and civil liabilities arising from an investigation by the US Department of Justice into manufacturing violations at a plant in Northern India.

http://panel.opinionhealth.com/r/9859 2011-12-23T08:15:18Z

The Medicines and Healthcare products Regulatory Agency (MHRA) has launched a 12-week consultation on proposals to change some of the fees it charges for the regulation of medicines.

http://panel.opinionhealth.com/r/9858 2011-12-20T08:35:05Z The Guardian

Australians born with birth defects after their mothers took thalidomide win right to have case heard in their own country

http://panel.opinionhealth.com/r/9857 2011-12-20T08:34:47Z

New evidence shows that Thomas Lonngren, former head of the European Medicines Agency (EMA), set up his own consultancy business to advise pharmaceutical industry clients while he was still employed as the EMA's head, according to pressure groups.

http://panel.opinionhealth.com/r/9855 2011-12-20T08:34:33Z

The latest set of opinions from the European Medicines Agency has brought good news for Roche and Daiichi Sankyo's personalised cancer drug Zelboraf.

http://panel.opinionhealth.com/r/9854 2011-12-20T08:34:16Z

ISTA Pharmaceuticals has rejected a hostile takeover bid from Valeant Pharmaceuticals International worth around $327 million, describing the proposal as "grossly inadequate".